PMC:7301188 / 17783-19488 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"456","span":{"begin":450,"end":453},"obj":"Gene"},{"id":"457","span":{"begin":116,"end":119},"obj":"Gene"}],"attributes":[{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"Gene:58492"},{"id":"A457","pred":"tao:has_database_id","subj":"457","obj":"Gene:1645"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Parameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T139","span":{"begin":213,"end":215},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T140","span":{"begin":330,"end":332},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T141","span":{"begin":361,"end":363},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T142","span":{"begin":682,"end":684},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T143","span":{"begin":901,"end":903},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T144","span":{"begin":957,"end":959},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T145","span":{"begin":968,"end":970},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T146","span":{"begin":1023,"end":1025},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T147","span":{"begin":1268,"end":1270},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T148","span":{"begin":1287,"end":1289},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T149","span":{"begin":1299,"end":1301},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T150","span":{"begin":1354,"end":1356},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T151","span":{"begin":1502,"end":1508},"obj":"http://purl.obolibrary.org/obo/CLO_0001174"},{"id":"T152","span":{"begin":1617,"end":1619},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"}],"text":"Parameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T96","span":{"begin":125,"end":127},"obj":"Chemical"},{"id":"T97","span":{"begin":459,"end":461},"obj":"Chemical"},{"id":"T98","span":{"begin":782,"end":784},"obj":"Chemical"},{"id":"T99","span":{"begin":1121,"end":1123},"obj":"Chemical"},{"id":"T100","span":{"begin":1453,"end":1455},"obj":"Chemical"}],"attributes":[{"id":"A96","pred":"chebi_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A97","pred":"chebi_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A99","pred":"chebi_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"}],"text":"Parameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05"}

    LitCovid-PD-GlycoEpitope

    {"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T15","span":{"begin":116,"end":119},"obj":"GlycoEpitope"}],"attributes":[{"id":"A15","pred":"glyco_epitope_db_id","subj":"T15","obj":"http://www.glycoepitope.jp/epitopes/AN0523"}],"text":"Parameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T164","span":{"begin":0,"end":65},"obj":"Sentence"},{"id":"T165","span":{"begin":66,"end":115},"obj":"Sentence"},{"id":"T166","span":{"begin":116,"end":180},"obj":"Sentence"},{"id":"T167","span":{"begin":181,"end":234},"obj":"Sentence"},{"id":"T168","span":{"begin":235,"end":287},"obj":"Sentence"},{"id":"T169","span":{"begin":288,"end":340},"obj":"Sentence"},{"id":"T170","span":{"begin":341,"end":388},"obj":"Sentence"},{"id":"T171","span":{"begin":389,"end":420},"obj":"Sentence"},{"id":"T172","span":{"begin":421,"end":449},"obj":"Sentence"},{"id":"T173","span":{"begin":450,"end":518},"obj":"Sentence"},{"id":"T174","span":{"begin":519,"end":556},"obj":"Sentence"},{"id":"T175","span":{"begin":557,"end":616},"obj":"Sentence"},{"id":"T176","span":{"begin":617,"end":661},"obj":"Sentence"},{"id":"T177","span":{"begin":662,"end":709},"obj":"Sentence"},{"id":"T178","span":{"begin":710,"end":741},"obj":"Sentence"},{"id":"T179","span":{"begin":742,"end":770},"obj":"Sentence"},{"id":"T180","span":{"begin":771,"end":840},"obj":"Sentence"},{"id":"T181","span":{"begin":841,"end":886},"obj":"Sentence"},{"id":"T182","span":{"begin":887,"end":947},"obj":"Sentence"},{"id":"T183","span":{"begin":948,"end":1002},"obj":"Sentence"},{"id":"T184","span":{"begin":1003,"end":1050},"obj":"Sentence"},{"id":"T185","span":{"begin":1051,"end":1082},"obj":"Sentence"},{"id":"T186","span":{"begin":1083,"end":1111},"obj":"Sentence"},{"id":"T187","span":{"begin":1112,"end":1176},"obj":"Sentence"},{"id":"T188","span":{"begin":1177,"end":1221},"obj":"Sentence"},{"id":"T189","span":{"begin":1222,"end":1278},"obj":"Sentence"},{"id":"T190","span":{"begin":1279,"end":1333},"obj":"Sentence"},{"id":"T191","span":{"begin":1334,"end":1381},"obj":"Sentence"},{"id":"T192","span":{"begin":1382,"end":1414},"obj":"Sentence"},{"id":"T193","span":{"begin":1415,"end":1443},"obj":"Sentence"},{"id":"T194","span":{"begin":1444,"end":1456},"obj":"Sentence"},{"id":"T195","span":{"begin":1457,"end":1497},"obj":"Sentence"},{"id":"T196","span":{"begin":1498,"end":1553},"obj":"Sentence"},{"id":"T197","span":{"begin":1554,"end":1596},"obj":"Sentence"},{"id":"T198","span":{"begin":1597,"end":1644},"obj":"Sentence"},{"id":"T199","span":{"begin":1645,"end":1676},"obj":"Sentence"},{"id":"T200","span":{"begin":1677,"end":1705},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Parameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05"}